Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
The validity of the distress thermometer in patients with primary open-angle glaucoma
Author Affiliations & Notes
  • Samuel Berchuck
    Duke University, Durham, North Carolina, United States
  • Davina A Malek
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Alessandro Jammal
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Tamara Somers
    Duke University, Durham, North Carolina, United States
  • Felipe Medeiros
    University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Samuel Berchuck None; Davina Malek None; Alessandro Jammal None; Tamara Somers None; Felipe Medeiros None
  • Footnotes
    Support  Supported by National Institute of Health/National Eye Institute grant K99EY033027 (SIB). The funding organizations had no role in the design or conduct of this research.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4619. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samuel Berchuck, Davina A Malek, Alessandro Jammal, Tamara Somers, Felipe Medeiros; The validity of the distress thermometer in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4619.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In patients with primary open-angle glaucoma (POAG), psychosocial risk factors play an important role in morbidity and mortality. It is critical to identify patients with distress as early as possible to provide them with supportive resources. The aim of this study was to validate the distress thermometer (DT) in POAG patients and to explore the associations between distress, vision-related quality-of-life (vrQOL), self-efficacy and social support.

Methods : POAG patients were prospectively recruited from the Duke Eye Center from September 2022 to August 2023. Patients were contacted by email prior to a glaucoma appointment and asked to complete surveys related to their distress, including DT, Hospital Anxiety and Depression Scale (HADS) and anxiety (HADS-A) and depression (HADS-D) subscales, NEI Visual Functioning Questionnaire 9-item scale, Self-Efficacy for Managing Chronic Disease 6-item scale, and the Modified Medical Outcomes Study Social Support Survey 8-item. Larger values of each scale indicate higher levels of the underlying measure. Summary statistics are presented as mean and standard deviation along with Spearman correlation (r) coefficients and p-values.

Results : A total of 300 patients (age 68.44 (12.60), 52% female, 81% white) were included. Patients reported a mean DT of 3.37 (2.59). One-hundred thirty-two patients (44%) had a DT≥4, indicating moderate or severe distress. The mean HADS score was 9.21 (6.28) with moderate or severe distress (HADS≥14) in 22% of patients. DT was strongly correlated with anxiety and depression (HADS total r = 0.67, P < 0.001), with the correlation being stronger with anxiety (HADS-A, r = 0.66, P < 0.001) than depression (HADS-D, r = 0.54, P < 0.001). For DT≥4, the sensitivity and specificity were 0.84 and 0.67, respectively, for detecting moderate or severe distress with an AUC of 0.82. DT was shown to have a moderate negative correlation with vrQOL (r = -0.28, P < 0.001), self-efficacy (r = -0.35, P < 0.001), and social support (r = -0.37, P < 0.001).

Conclusions : Our study indicates that nearly half of POAG patients had relevant distress and that a brief screening tool can be used in glaucoma clinics. Increased vision-related quality-of-life, self-efficacy, and social support were associated with lower patient distress, highlighting the importance of non-pharmacological interventions to improve distress in POAG patients.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×